Philogen SpA (MIL:PHIL) Preferred Dividends : €0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Philogen SpA's preferred dividends for the six months ended in Jun. 2024 was €0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Philogen SpA Preferred Dividends Historical Data

The historical data trend for Philogen SpA's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Preferred Dividends Chart

Philogen SpA Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Philogen SpA Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Preferred Dividends	Get a 7-Day Free Trial				-	-	-	-	-

Philogen SpA Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Philogen SpA (MIL:PHIL) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Philogen SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (MIL:PHIL) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

78Q:Germany

Address

Piazza La Lizza No. 7, Siena, ITA, 53100

Website

https://www.philogen.com

Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.